Age-related Macular Degeneration (AMD) –
The disease

Age-related macular degeneration (AMD) is a progressive, degenerative disease of the macula. The macula includes the place of the sharpest vision, the foveola. The macula is pigmented yellow in the healthy state (“yellow spot”). It processes all stimuli that we perceive in the central visual field. This is why AMD can eventually cause vision loss in the central visual field, which makes it difficult to read or recognize faces.

For people over 65 year of age, AMD is the most common cause of blindness in the industrialized countries. Early stages of AMD are found in about 20% of the 65- to 74-year-olds and in about 35% of the 75- to 84-year-olds. Due to the changing age demographic, the population that is affected by AMD will continue to rise in the coming years and decades.


The MMT 2.0 can easily detect early signs of maculopathy. In addition, the MMT 2.0 allows determining residual vision in people with already diagnosed retinal diseases or documenting the progression of the disease. The MMT 2.0 is thus the ideal basis for successfully consulting your clients.